Home › Funds › Rock Springs Capital Management LP › RYTM

Rock Springs Capital Management LP position in RYTM

RHYTHM PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 692,598 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$65.9M, representing 3.57% of its reported portfolio and ranking #6 among its reported holdings. Rock Springs Capital Management LP has disclosed RYTM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)692.60K sh
Reported value held$65.95M
Portfolio Weight3.57%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's RYTM position evolved

Rock Springs Capital Management LP first disclosed a stake in RYTM in Q3 2023 at 1,597,123 shares (US$36.6M). The position peaked in Q2 2026 at 692,598 shares, worth US$76.9M. Across 13 filings, Rock Springs Capital Management LP increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 692,598 shares valued at US$65.9M. Notable position changes include a 28% trim in Q1 2025 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.60M $36.61M New
Q4 2023 1.52M $70.01M Reduce
Q1 2024 1.52M $65.99M Hold
Q2 2024 1.28M $52.58M Reduce
Q3 2024 1.23M $64.34M Reduce
Q4 2024 1.16M $65.09M Reduce
Q1 2025 834.19K $44.19M Reduce
Q2 2025 861.15K $54.42M Add
Q3 2025 717.10K $72.42M Reduce
Q4 2025 695.01K $74.39M Reduce
Q1 2026 689.75K $59.99M Reduce
Q2 2026 692.60K $76.90M Hold
Q3 2026 692.60K $65.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RYTM and 13F data

RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RYTM

All RYTM fund holders →

FAQ

How long has Rock Springs Capital Management LP held RYTM?

Rock Springs Capital Management LP has disclosed RYTM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in RYTM?

As of Q3 2026, Rock Springs Capital Management LP holds 692.60K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $65.95M, representing 3.57% of its reported portfolio and ranking #6.

Has Rock Springs Capital Management LP been buying or selling RYTM?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP held unchanged its position in RYTM. The position peaked in Q2 2026 at 692.60K shares.

Which other funds hold RYTM?

Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.